We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.58B
AUM Growth
+$568M
Cap. Flow
+$189M
Cap. Flow %
3.39%
Top 10 Hldgs %
17.58%
Holding
1,590
New
158
Increased
732
Reduced
501
Closed
88

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$10.8M
2
C icon
Citigroup
C
+$10.8M
3
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$7.17M
4
PARA
Paramount Global Class B
PARA
+$7.03M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.79M

Top Sells

Rank Stock Value
1
CWB icon
State Street SPDR Bloomberg Convertible Securities ETF
CWB
+$8.63M
2
USB icon
US Bancorp
USB
+$8.6M
3
AWI icon
Armstrong World Industries
AWI
+$7.38M
4
BMY icon
Bristol-Myers Squibb
BMY
+$5.97M
5
NKE icon
Nike
NKE
+$4.7M

Sector Composition

Rank Sector Weight
1 Technology 17.89%
2 Financials 10.71%
3 Healthcare 10.59%
4 Consumer Discretionary 9.99%
5 Industrials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FPL
1476
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$80K ﹤0.01%
13,553
+100
+0.7% +$570
CMCM
1477
Cheetah Mobile
CMCM
$88.5M
$74K ﹤0.01%
6,204
– –
ADIL
1478
Adial Pharmaceuticals
ADIL
$7.2M
$71K ﹤0.01%
45
+22
+96% +$33.5K
VVR icon
1479
Invesco Senior Income Trust
VVR
$459M
$69K ﹤0.01%
15,500
-21,257
-58% -$90.8K
GMDA
1480
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$69K ﹤0.01%
10,800
– –
NBSE
1481
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$61K ﹤0.01%
638
+100
+19% +$11K
SENS icon
1482
Senseonics Holdings Inc
SENS
$265M
$58K ﹤0.01%
750
+250
+50% +$12.7K
OPK icon
1483
Opko Health
OPK
$993M
$55K ﹤0.01%
13,500
-1,000
-7% -$3.92K
IEAWW
1484
DELISTED
Infrastructure and Energy Alternatives, Inc. Warrant
IEAWW
$54K ﹤0.01%
25,000
– –
NGD
1485
DELISTED
New Gold Inc
NGD
$49K ﹤0.01%
26,946
– –
VERO
1486
DELISTED
Venus Concept
VERO
$48K ﹤0.01%
+94
New +$33.9K
PVLA
1487
Palvella Therapeutics
PVLA
$2.15B
$47K ﹤0.01%
153
-85
-36% -$18.6K
TXMD icon
1488
TherapeuticsMD
TXMD
$23.5M
$46K ﹤0.01%
765
-20
-3% -$1.21K
WATT icon
1489
Energous
WATT
$77.2M
$46K ﹤0.01%
27
– –
AEG icon
1490
Aegon
AEG
$14B
$42K ﹤0.01%
10,959
-1,309
-11% -$5.57K
EGIO
1491
DELISTED
Edgio, Inc. Common Stock
EGIO
$42K ﹤0.01%
330
-46
-12% -$6.07K
AMPE
1492
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$42K ﹤0.01%
84
– –
OTLK icon
1493
Outlook Therapeutics
OTLK
$194M
$34K ﹤0.01%
680
+25
+4% +$1.16K
TOON icon
1494
Kartoon Studios
TOON
$35.1M
$22K ﹤0.01%
1,180
-8,290
-88% -$145K
WRN
1495
Western Copper and Gold
WRN
$476M
$20K ﹤0.01%
10,000
– –
GSAT icon
1496
Globalstar
GSAT
$10.3B
$18K ﹤0.01%
667
– –
ATHX
1497
DELISTED
Athersys, Inc. Common Stock
ATHX
$14K ﹤0.01%
400
– –
DMK
1498
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$13K ﹤0.01%
171
– –
NMTR
1499
DELISTED
9 Meters Biopharma
NMTR
$12K ﹤0.01%
+545
New +$13.4K
GAB.RT
1500
DELISTED
The Gabelli Equity Trust Inc. Rights (expiring July 14, 2021)
GAB.RT
$5K ﹤0.01%
+44,550
New +$5.18K
58 59
60
61 62

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Oppenheimer & Co held 1,590 positions worth $5.58B, up 11% from $5.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co deployed $189M of net new capital in Q2 2021, opening 158 new positions and adding to 732 existing holdings. Its largest new stake was Equity Commonwealth: 133,173 shares worth $3.49M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg Convertible Securities ETF, an estimated $8.63M trimmed.

  • Oppenheimer & Co's largest Q2 2021 buy was Equity Commonwealth: 133,173 shares worth $3.49M.
  • Oppenheimer & Co added most to Amazon in Q2 2021, an estimated $10.8M increase.
  • Oppenheimer & Co's biggest Q2 2021 reduction was State Street SPDR Bloomberg Convertible Securities ETF, cutting an estimated $8.63M.
  • Oppenheimer & Co fully exited Armstrong World Industries in Q2 2021, selling an estimated $7.38M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.58B portfolio in Q2 2021.
  • Oppenheimer & Co opened 158 new positions and closed 88 in Q2 2021.
  • Oppenheimer & Co's portfolio value rose 11% quarter-over-quarter to $5.58B.

Based on Oppenheimer & Co's 13F filing for Q2 2021, filed 3 Aug 2021.